Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 7e-05 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0003 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |